Compare Toyota Motor Corp (TM) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Toyota Motor Corp vs Zimmer Biomet Holdings Inc — how do they compare? Toyota Motor Corp trades at $184.37 (market cap $216.99B), while Zimmer Biomet Holdings Inc trades at $88.9 (market cap $16.88B). The key difference: Toyota Motor Corp is far larger — about 12.9× Zimmer Biomet Holdings Inc's market cap, and Toyota Motor Corp pays the higher dividend (3.43%). Which is the better fit depends on your goals — on Pluang, investors hold Toyota Motor Corp for 116 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| TM | ZBH | |
|---|---|---|
Market Cap | $216.99B | $16.88B |
Volume | 314,929 | 1,991,354 |
Sector | Consumer Cyclical | Health |
52-Week High | $248.29 | $103.98 |
52-Week Low | $166.50 | $79.58 |
Typical Hold Time | 116 Days | 89 Days |
Enterprise Value | $410.32B | $23.95B |
Dividend Yield | 3.43% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Toyota Motor trades at $182.91, down 1.43% with bearish technical signals but attractive valuation metrics including P/E of 8.22 and P/B of 0.92. The company reported strong Q2 2026 earnings beat with EPS of $7.57 versus $4.68 expected, though revenue growth has moderated to 6.5% year-over-year. Recent news highlights Toyota's expanding electrified vehicle lineup and U.S. market share gains, while facing production challenges from Thailand floods and China sales weakness.
Toyota presents a value opportunity with solid profitability (8.63% net margin) and consistent earnings beats, but faces near-term headwinds from production disruptions and competitive pressures. Analyst consensus leans cautious with 62.5% hold ratings, suggesting the stock may consolidate near current levels despite attractive valuation multiples.
Zimmer Biomet (ZBH) trades at $88.91, down 0.86% on the day, with a bearish technical signal from moving averages. The company reported revenue of $8.23B in 2025, with net income of $705.1M, and has beaten EPS estimates for the last three quarters. Recent news highlights a quarterly dividend declaration and leadership promotions aimed at accelerating commercial transformation.
The outlook is mixed: strong fundamentals and consistent earnings beats support growth, but technical indicators and rising debt-to-asset ratios pose risks. Analyst consensus suggests a 16% upside to the $103.11 price target, though nearly half of analysts recommend Hold. Key risks include competitive pressures and execution of the company's strategic initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
